Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and pharmacokinetics of CKD-330
(fixed-dose combination of Candesartan 16 mg and Amlodipine 5 mg) with coadministration of
the two separate drugs in healthy male volunteers.